2023
DOI: 10.1038/s44161-022-00201-x
|View full text |Cite
|
Sign up to set email alerts
|

Challenges and opportunities to improving research in maternal cardiovascular health

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…This finding reaffirms previous research highlighting age-related changes including both structural changes such as increased LV wall mass 43 , possibly driven by cardiomyocyte hypertrophy and functional changes such as the decline in diastolic function 24,44 . This decline in the CV may be driven by well-established age-related cellular and tissue level remodelling including impaired sodium channel function 44 (potentially though loss-of-function genetic mutations such as SCN5A as identified in previous ECG age-delta GWAS 45 and experimental studies 46 ) and the development of myocardial fibrosis 24,47 . It may also be affected by gap junction decoupling such as connexin 43 downregulation which is a known pathological remodelling in patients with ventricular hypertrophy and ischaemic heart diseases 48 .…”
Section: Discussionmentioning
confidence: 99%
“…This finding reaffirms previous research highlighting age-related changes including both structural changes such as increased LV wall mass 43 , possibly driven by cardiomyocyte hypertrophy and functional changes such as the decline in diastolic function 24,44 . This decline in the CV may be driven by well-established age-related cellular and tissue level remodelling including impaired sodium channel function 44 (potentially though loss-of-function genetic mutations such as SCN5A as identified in previous ECG age-delta GWAS 45 and experimental studies 46 ) and the development of myocardial fibrosis 24,47 . It may also be affected by gap junction decoupling such as connexin 43 downregulation which is a known pathological remodelling in patients with ventricular hypertrophy and ischaemic heart diseases 48 .…”
Section: Discussionmentioning
confidence: 99%